Search research articles
Contact Us
Filters
Showing results (161-170 of 181) with videos related to
Page
of 19
Sort By:
Regulatory Toxicology and Pharmacology : RTP
|
February 25, 2017
Quantitative weight of evidence to assess confidence in potential modes of action
Richard A Becker, Vicki Dellarco, Jennifer Seed, et al.
Scientific Reports
|
May 26, 2021
COVID-19 infection data encode a dynamic reproduction number in response to policy decisions with secondary wave implications
Michael A Rowland, Todd M Swannack, Michael L Mayo, et al.
Risk Management and Healthcare Policy
|
July 16, 2021
Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?
Jeffrey C Cegan, Benjamin D Trump, Susan M Cibulsky, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 12, 2015
Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence
Richard A Becker, Gerald T Ankley, Stephen W Edwards, et al.
Nature Nanotechnology
|
October 9, 2024
Nanotechnology solutions for the climate crisis
Maria Fernanda Campa, Craig M Brown, Peter Byrley, et al.
Integrated Environmental Assessment and Management
|
May 25, 2011
The challenges posed by radiation and radionuclide releases to the environment
Richard J Wenning, Sabine E Apitz, Thomas Backhaus, et al.
Environment International
|
March 8, 2016
LICARA nanoSCAN - A tool for the self-assessment of benefits and risks of nanoproducts
Toon van Harmelen, Esther K Zondervan-van den Beuken, Derk H Brouwer, et al.
Integrated Environmental Assessment and Management
|
December 17, 2016
Environmental policy recommendations for the new US President
Sabine Apitz, Roberta Attanasio, Thomas Backhaus, et al.
Environmental Science. Nano
|
April 16, 2025
U. S. federal perspective on critical research issues in nanoEHS
Janet Carter, Rhema Bjorkland, William K Boyes, et al.
EMBO Reports
|
January 4, 2026
Governing the AI-biotech convergence : The rapid progress in and the dual-use nature of biotechnology and AI requires adaptive and resilient regulatory frameworks to address potential risks
Benjamin D Trump, Christopher L Cummings, Beth Ellinport, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 181) with videos related to
Sort By:
Page
of 19
Regulatory Toxicology and Pharmacology : RTP
|
February 25, 2017
Quantitative weight of evidence to assess confidence in potential modes of action
Richard A Becker, Vicki Dellarco, Jennifer Seed, et al.
Scientific Reports
|
May 26, 2021
COVID-19 infection data encode a dynamic reproduction number in response to policy decisions with secondary wave implications
Michael A Rowland, Todd M Swannack, Michael L Mayo, et al.
Risk Management and Healthcare Policy
|
July 16, 2021
Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?
Jeffrey C Cegan, Benjamin D Trump, Susan M Cibulsky, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 12, 2015
Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence
Richard A Becker, Gerald T Ankley, Stephen W Edwards, et al.
Nature Nanotechnology
|
October 9, 2024
Nanotechnology solutions for the climate crisis
Maria Fernanda Campa, Craig M Brown, Peter Byrley, et al.
Integrated Environmental Assessment and Management
|
May 25, 2011
The challenges posed by radiation and radionuclide releases to the environment
Richard J Wenning, Sabine E Apitz, Thomas Backhaus, et al.
Environment International
|
March 8, 2016
LICARA nanoSCAN - A tool for the self-assessment of benefits and risks of nanoproducts
Toon van Harmelen, Esther K Zondervan-van den Beuken, Derk H Brouwer, et al.
Integrated Environmental Assessment and Management
|
December 17, 2016
Environmental policy recommendations for the new US President
Sabine Apitz, Roberta Attanasio, Thomas Backhaus, et al.
Environmental Science. Nano
|
April 16, 2025
U. S. federal perspective on critical research issues in nanoEHS
Janet Carter, Rhema Bjorkland, William K Boyes, et al.
EMBO Reports
|
January 4, 2026
Governing the AI-biotech convergence : The rapid progress in and the dual-use nature of biotechnology and AI requires adaptive and resilient regulatory frameworks to address potential risks
Benjamin D Trump, Christopher L Cummings, Beth Ellinport, et al.
Page
of 19